Research
MY CHILD FACING CANCER
MY CHILD FACING CANCER
In France, the care of children with cancer is adapted to each case, in order to guarantee effective care, while respecting the quality of life of the young patient. THE STAGES OF THE TREATMENT JOURNEY The care of a child with cancer is embodied in the “care pathway”, which unfolds in seven complementary areas: The […]HOW CAN YOU HELP CHILDHOOD CANCER RESEARCH?
HOW CAN YOU HELP CHILDHOOD CANCER RESEARCH?
The leading cause of death by disease in children over the age of one, pediatric cancers can only be completely cured one day thanks to advances in research. RESEARCH AGAINST CHILDHOOD CANCER IN FRANCE AND EUROPE Childhood cancer research, in France and in Europe, focuses on: Improve knowledge of the causes of pediatric cancers, Dealing […]TRIBUNE – PEDIATRIC CANCERS: THE END OF INJUSTICE WITHIN REACH
TRIBUNE – PEDIATRIC CANCERS: THE END OF INJUSTICE WITHIN REACH
For World Childhood Cancer Day, Patricia BLANC, Founding President of Imagine for Margo and Patrick ERRARD, member of the Strategic Orientation Committee of Imagine for Margo call in a forum to lift the legislative constraints and to create a new ecosystem to build a world with children without cancer. Nearly one in 440 children will […]WHAT IS CHILDHOOD AND YOUTH CANCER?
WHAT IS CHILDHOOD AND YOUTH CANCER?
Like any cancer, pediatric cancers correspond to the disruption of a cell which, by multiplying, will disrupt the normal functioning of the body. Today, there are 100 different types of cancer in children and teenagers that affect 2,500 little warriors in France every year. CANCER: A SINGULAR NAME FOR A MULTIPLE DISEASE We often talk […]2 ADDITIONAL RESEARCH PROJECTS FUNDED BY FIGHT KIDS CANCER 2022!
2 ADDITIONAL RESEARCH PROJECTS FUNDED BY FIGHT KIDS CANCER 2022!
In June 2022, 5 research programs were selected by Fight Kids Cancer for funding thanks to our solidarity race Children without Cancer as well as those of our European partners KickCancer (Belgium), Kriibskrank Kanner (Luxembourg) and Fiagop (Italy). Excellent news: following the 4 races organized in September, 2 additional research projects can be funded this […]INCLUSION OF THE FIRST PATIENTS IN THE ASIDNA CLINICAL TRIAL
INCLUSION OF THE FIRST PATIENTS IN THE ASIDNA CLINICAL TRIAL
On the occasion of the opening of the international month for the fight against childhood cancer, the Institut Curie and the biotech Onxeo announced the inclusion of the 1st patient in the AsiDNA clinical trial funded by our European call for projects Fight Kids Cancer. The latter aims at assessing the effectiveness of AsiDNATM, a […]BIOMEDE 2.0, A NEW HOPE AGAINST INFILTRATING GLIOMA OF THE BRAIN STEM
BIOMEDE 2.0, A NEW HOPE AGAINST INFILTRATING GLIOMA OF THE BRAIN STEM
On September 23, BIOMEDE 2.0 opened. This international clinical trial, which we are financially supporting, is dedicated to malignant midline and brainstem gliomas. Its objective: to compare a promising drug, ONC201, with everolimus, a current targeted therapy treatment. Today, 10 to 15% of malignant brain tumors in children are infiltrating brainstem gliomas. Despite progress in […]UNCAN: A EUROPEAN PROJECT TO BETTER UNDERSTAND CANCERS
